Drugs / K1-70
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02904330 | Aug 2016 → Apr 2021 | Graves disease | AV7 Limited | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | K1-70 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02904330 ↗ |
| Action | Inhibit | “K1-70 is a thyroid stimulating hormone receptor antagonist” NCT02904330 ↗ |
| Route | Intramuscular | “K1-70 by IM injection” NCT02904330 ↗ |